Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
06/12/2002 | CN1086115C Preparation process and product of nutritive glossy ganoderma liquid |
06/11/2002 | US6403860 Ku80 homologue and uses thereof |
06/11/2002 | US6403775 Erythronolide compounds |
06/11/2002 | US6403765 Truncated Apaf-1 and methods of use thereof |
06/11/2002 | US6403559 C-kit ligand-based method for expanding peripheral blood cell levels |
06/11/2002 | US6403557 Fibroblast growth factor-13 |
06/11/2002 | US6403376 Vitrification; cooling; controlling temperature |
06/11/2002 | US6403374 Long wavelength engineered fluorescent proteins |
06/11/2002 | US6403372 Aspergillus fumigatus profilin |
06/11/2002 | US6403362 Systems for the mass production of proteins or peptides by microorganisms of the genus humicola |
06/11/2002 | US6403361 Enzymatic method for modification of recombinant polypeptides |
06/11/2002 | US6403360 Isolated nucleic acids |
06/11/2002 | US6403356 Mutant penicillin G acylases |
06/11/2002 | US6403354 Dna from bacillus; genetic engineering |
06/11/2002 | US6403351 Regenerates oxaloacetate consumed during lysine and glutamic acid production in industrial fermentation ; amino acid sequence |
06/11/2002 | US6403349 Elongation of polyunsaturated fatty acid such as linolenic acid to dihomogamma linolenic acid; nucleotide sequence encodes polypeptide; genetic engineering; animal feeds, nutrients, cosmetics |
06/11/2002 | US6403345 Culturing, fermentation, obtaining biomass; purification; foods, drugs, cosmetics |
06/11/2002 | US6403342 DNA coding for mutant isopropylmalate synthase L-leucine-producing microorganism and method for producing L-leucine |
06/11/2002 | US6403337 Staphylococcus aureus genes and polypeptides |
06/11/2002 | US6403336 Dna segment encodes protective peptide-fused atriopeptin; microorganisms transformed with vectors; genetic engineering |
06/11/2002 | US6403335 Amino acid sequence; promotes survival of mesencephalic cells; nervous system and degenerative disorders; parkinson*s disease; genetic engineering |
06/11/2002 | US6403103 Cytoplasmic protein fragment selected from: the amino acid sequence from residue 402 to residue 426 of seq id no: 2; and an immunogenic fragment of said amino acid sequence comprising at least residue 408 to residue 417 of said amino acid |
06/11/2002 | US6403102 Chlamydia antigens and corresponding DNA fragments and uses thereof |
06/11/2002 | US6403101 Chlamydia antigens and corresponding DNA fragments and uses thereof |
06/11/2002 | US6403094 Clostridium perfringens vaccines |
06/11/2002 | US6403091 Produced by the hybridoma having atcc accession no. hb 10916. |
06/11/2002 | US6403082 Administering polynucleotide |
06/11/2002 | CA2169629C Human erythropoietin receptor fragment and antibodies thereto |
06/11/2002 | CA2156439C Urea-surfactant clathrates and their use in bioremediation of hydrocarbon contaminated soils and water |
06/11/2002 | CA2095861C Structural proteins from artificial genes |
06/11/2002 | CA1341367C Enhanced production of proteins by cell culture |
06/06/2002 | WO2002044734A1 Method for diagnosing a tumor in a patient determining the concentration of pibf |
06/06/2002 | WO2002044406A2 Projection against mycobacterial infections |
06/06/2002 | WO2002044388A1 Production of heterologous polypeptides in yeast |
06/06/2002 | WO2002044380A2 Master bone formation transcription factor: compositions and methods of use |
06/06/2002 | WO2002044379A2 Transforming growth factor-beta-related molecules and uses thereof |
06/06/2002 | WO2002044377A2 Obp1:a protein selectively expressed in osteoblasts |
06/06/2002 | WO2002044374A2 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof |
06/06/2002 | WO2002044371A1 Human protooncogene and protein encoded therein |
06/06/2002 | WO2002044370A1 Human cervical cancer 2 protooncogene and protein encoded therein |
06/06/2002 | WO2002044369A1 Novel human chloride channel |
06/06/2002 | WO2002044366A2 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 |
06/06/2002 | WO2002044364A2 Polypeptides involved in immune response |
06/06/2002 | WO2002044362A1 Method of screening remedy for diabetes |
06/06/2002 | WO2002044361A2 Eukaryotic expression libraries based on double lox recombination and methods of use |
06/06/2002 | WO2002044355A2 Protozoan expression systems for lysosomal storage disease genes |
06/06/2002 | WO2002044352A1 Bacteriolytic complex, method for producing said complex and strain for carrying out said method. |
06/06/2002 | WO2002044350A2 Cyclodextrin glucanotransferase (cgtase), obtained from bacillus agaradherens (dsm 9948) and detergents and cleaning agents containing said novel cyclodextrin glucanotransferase |
06/06/2002 | WO2002044336A2 Method of making a protein polymer and uses of the polymer |
06/06/2002 | WO2002044321A2 Rna interference mediating small rna molecules |
06/06/2002 | WO2002044320A2 Human elongase genes and uses thereof |
06/06/2002 | WO2002044210A2 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain |
06/06/2002 | WO2002044209A2 Cytonkine receptor zcytor19 |
06/06/2002 | WO2002044206A2 Membrane fusion proteins derived from reovirus |
06/06/2002 | WO2002044203A2 Production of recombinant bmp-2 |
06/06/2002 | WO2002044199A2 Neurotoxins with enhanced target specificity |
06/06/2002 | WO2002043661A2 Recombinant anti-cd30 antibodies and uses thereof |
06/06/2002 | WO2002043649A2 Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof |
06/06/2002 | WO2002024737A8 Nucleotide sequences which code for the dps gene of c. glutamicum |
06/06/2002 | WO2002018428A3 Sequences which code for the sige gene of corynebacterium glutamicum |
06/06/2002 | WO2002013606A3 Improved insecticidal bacteria, and methods for making and using them |
06/06/2002 | WO2002005843A3 Human rrp sequences and methods of use |
06/06/2002 | WO2002002606A3 Immunisation against chlamydia pneumoniae |
06/06/2002 | WO2001096557A3 A human homologue of the dbf4/ask1 protein, nucleic acids, and methods related to the same |
06/06/2002 | WO2001094414A3 THE HUMAN VOLTAGE GATED SODIUM CHANNEL β-1A SUBUNIT AND METHODS OF USE |
06/06/2002 | WO2001090360A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
06/06/2002 | WO2001090334A3 Drug metabolizing enzymes |
06/06/2002 | WO2001079442A3 Albumin fusion proteins |
06/06/2002 | WO2001064907A3 Lipid metabolism enzymes |
06/06/2002 | WO2001064884A3 G12l, a gene associated with the thermal response |
06/06/2002 | WO2001048209B1 Genes identified as required for proliferation of e. coli |
06/06/2002 | WO2001036645A3 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same |
06/06/2002 | WO2001023604A9 Highly conserved genes and their use to generate probes and primers for detection of microorganisms |
06/06/2002 | WO2000024782A3 Modified peptides, comprising an fc domain, as therapeutic agents |
06/06/2002 | US20020069422 Proteins for use in the treatment of trypanosome infection, cancer, inflammation and immunological defects |
06/06/2002 | US20020068825 Polypeptide for use in the treatment of nervous system disorders |
06/06/2002 | US20020068824 Membrane protein for use in the treatnment of diabetes, hypotension, endocrine defects |
06/06/2002 | US20020068816 For diagnosis, prevention or treatment of cancer, AIDS, immunodeficiencies, autoimmune diseases, inflammatory diseases, and proliferative diseases |
06/06/2002 | US20020068716 Pituitary-tumor-transforming-gene (PTTG) polypeptide expressed by pituitary tumor cells, which binds anti-PTTG antibody. |
06/06/2002 | US20020068697 Peptides blocking vascular endothelial growth factor (VEGF) -mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof |
06/06/2002 | US20020068694 Glycosylated VEGF-B and method for increasing the amount of soluble VEGF-B |
06/06/2002 | US20020068363 Enhancing cell competence by recursive sequence recombination |
06/06/2002 | US20020068360 Preserving cells; obtain cells incubate with freeze resistant mixture, reduce heat, monitor cells |
06/06/2002 | US20020068356 Method of removing gas from a site using gas vesicles of cells |
06/06/2002 | US20020068353 Nucleotide sequence coding tumor polypeptide for use as anticarcinogeneic agents |
06/06/2002 | US20020068350 Enzymatic polypeptide for use in nutrients of animal feeds |
06/06/2002 | US20020068349 Nucleotide sequences coding enzymatic polypeptide for use in the generation of trehalose |
06/06/2002 | US20020068347 Membrane protein for use in the diagnosis and prevention of cancer |
06/06/2002 | US20020068346 Enzymatic polypeptide for use in the prevention and treatment of viral diseases |
06/06/2002 | US20020068341 Human kallikrein |
06/06/2002 | US20020068336 Nucleotide sequences which code for the CcpA2 gene |
06/06/2002 | US20020068335 Processes for preparing D-pantothenic acid using coryneform bacteria |
06/06/2002 | US20020068330 Composition for use in the propagation of bacteria |
06/06/2002 | US20020068329 Fusion proteins for prodrug activation |
06/06/2002 | US20020068325 Methods and compositions for highly efficient production of heterologous proteins in yeast |
06/06/2002 | US20020068323 Nucleotide sequences which code polypeptide for use in human therapeutics ad diagnostics |
06/06/2002 | US20020068319 32 human secreted proteins |
06/06/2002 | US20020068314 Method of detecting mycobacteria |
06/06/2002 | US20020068289 Screening library for preferential clones; obtain sample from library, insert into expression vector, transform cell, monitor cells for preferential gene expression, detect expression of preferential fuson protein |
06/06/2002 | US20020068286 Detecting modulators of gene associated with weight control; obtain cells incubate with modulator, measure expression of preferential genes, compare to control |